CIRCULATING TUMOR CELLS (CTC) AND PROSTATE-SPECIFIC ANTIGEN (PSA) AS RESPONSE INDICATOR BIOMARKERS IN CHEMOTHERAPY-NAIVE PATIENTS WITH PROGRESSIVE CASTRATION-RESISTANT PROSTATE CANCER (CRPC) TREATED WITH MDV3100

被引：0
|
作者：
Hirmand, M. [1 ]
Scher, H. I. [2 ]
Beer, T. [3 ]
Higano, C. S. [4 ]
Taplin, M. [5 ]
Efstathiou, E. [6 ]
机构：
[1] Medivation, Clin Dev, San Francisco, CA USA
[2] Mem Sloan Kettering Canc Ctr, Genitourinary Oncol Serv, New York, NY 10021 USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Univ Washington, Sch Med, Seattle, WA USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
[6] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：277 / 277
页数：1
相关论文
共 50 条
  • [1] Circulating tumor cells (CTC) and prostate specific antigen (PSA) as response indicator biomarkers in chemotherapy-naive patients with progressive castration-resistant prostate cancer(CRPC) treated with MDV3100.
    Anand, A.
    Scher, H. I.
    Beer, T. M.
    Higano, C. E.
    Danila, D. C.
    Taplin, M.
    Efstathiou, E.
    Hirmand, M.
    Sawyers, C. L.
    Heller, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] CLINICAL STUDY OF MDV3100 IN PROGRESSIVE CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
    Scher, Howard I.
    Beer, Tomasz
    Higano, Celestia
    Efstathiou, Eleni
    Anand, Aseem
    Hirmand, Mohammad
    Hung, David
    Steve, Larson
    Fleisher, Martin
    Sawyers, Charles
    JOURNAL OF UROLOGY, 2009, 181 (04): : 230 - 230
  • [3] Phase I/II study of MDV3100 in patients (pts) with progressive castration-resistant prostate cancer (CRPC)
    Scher, H. I.
    Beer, T. M.
    Higano, C. S.
    Danila, D. C.
    Montgomery, B.
    Shelkey, J.
    Hirmand, M.
    Hung, D.
    Sawyers, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Antitumor activity of MDV3100 in a phase I/II study of castration-resistant prostate cancer (CRPC)
    Scher, H. I.
    Beer, T. M.
    Higano, C. S.
    Taplin, M.
    Efstathiou, E.
    Anand, A.
    Hung, D.
    Hirmand, M.
    Fleisher, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] The expression of prostate-specific membrane antigen in circulating tumor cells (CTC) of castration-resistant prostate cancer: The association with poor treatment response
    Nagaya, N.
    Kanayama, M.
    Nagata, M.
    Horie, S.
    ANNALS OF ONCOLOGY, 2017, 28 : 78 - 78
  • [6] Circulating tumour cells (CTC) count and prostate-specific antigen (PSA) response measures in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with docetaxel (Doc)
    Lozano Mejorada, R.
    Lorente, D.
    Castro, E.
    Bianchini, D.
    Nombela, P.
    Sandhu, S. K.
    Romero Laorden, N.
    Cendon, Y.
    Sharp, A.
    Almagro Casado, E.
    Pacheco, M. I.
    Rescigno, P.
    Llacer, C.
    Saez, M.
    Rivera, L.
    Vitrone, F.
    Moreno, C.
    Mateo, J.
    de Bono, J. S.
    Olmos Hidalgo, D.
    ANNALS OF ONCOLOGY, 2019, 30 : 350 - 350
  • [7] Prostate-Specific Antigen Flare Phenomenon Induced by Abiraterone Acetate in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer
    Ueda, Yujiro
    Matsubara, Nobuaki
    Tabata, Ken-Ichi
    Satoh, Takefumi
    Kamiya, Naoto
    Suzuki, Hiroyoshi
    Kawahara, Takashi
    Uemura, Hiroji
    CLINICAL GENITOURINARY CANCER, 2017, 15 (02) : 320 - 325
  • [8] Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
    Bianchini, D.
    Lorente, D.
    Rodriguez-Vida, A.
    Omlin, A.
    Pezaro, C.
    Ferraldeschi, R.
    Zivi, A.
    Attard, G.
    Chowdhury, S.
    de Bono, J. S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (01) : 78 - 84
  • [9] Genomic analysis of circulating tumor cells (CTC) from patients with castration-resistant prostate cancer (CRPC) as predictive biomarkers
    Danila, D. C.
    Anand, A.
    Yao, J.
    Gierszewska, M.
    Kramer, M.
    Muller, S.
    Fleisher, M.
    McCombie, W. R.
    Scher, H. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Predictive biomarkers in circulating tumor cells (CTC) from patients with castration-resistant prostate cancer (CRPC) through genomic analysis
    Danila, Daniel Costin
    Anand, Aseem
    Yao, Jianchao
    Gierszewska, Magdalena
    Kramer, Melissa
    Muller, Stephanie
    Fleisher, Martin
    McCombie, William R.
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345